BioSpace News Archive

HMS Holdings Corp. (Nasdaq: HMSY) today announced financial results for the fourth quarter and full year ended December 31, 2019.

EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today that Trent Sullivan has joined the firm as a Producer in the firm’s Edgewood Healthcare Advisors’ Practice.

Following are the latest Coronavirus news releases and story ideas for reporters, bloggers and media outlets.

Leading telehealth provider TeleDaddy has received LegitScript’s Stamp of Approval.

Feb. 21, 2020 15:19 UTC Founder and CEO of Tolero Pharmaceuticals, David Bearss, Ph.D, and Managing Director and Head of Global Investment Opportunities Group of J.P. Morgan, Monica DiCenso, to address healthcare innovation and industry outlook at February 28 noted Utah life sciences event SALT LAKE CITY--( BUSINESS WIRE )-- BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Center for Technology &

Feb. 21, 2020 15:13 UTC STAMFORD, Conn.--( BUSINESS WIRE )-- Purdue Pharma L.P. (“Purdue”) today announced the appointment of former United States Agriculture Secretary and Iowa Governor Tom Vilsack as Monitor under the voluntary self-injunction approved on November 6, 2019, in its chapter 11 bankruptcy case. In its initial bankruptcy filings, Purdue voluntarily proposed to formalize under court order its commitment to continue to refrain from engaging in certain promotional

BUFFALO, N.Y. , Feb. 21, 2020 /PRNewswire/ -- Circuit Clinical, a recent winner of the 43North Finals, is thrilled to announce TrialScout’s #FindtheFive outreach campaign was recognized at the Summit for Clinical Operations Executives (SCOPE) in Orlando , Florida. On Tuesday evening, TrialScout’s #FindtheFive campaign was named t

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share.

New support may help Purdue University scientists target what they call one of the greatest threats to human health – antimicrobial resistance.

New high-performance chemistry combined with PCR-free DNBSEQ nanoarray platform delivers higher quality and more sequencing reads